English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Saturday, May 8, 2021
ACDX Offers World's First Leveraged Trading for Chia (XCH)
02:20 HKT/SGT
ACDX全球首发Chia奇亚XCH杠杆交易
02:19 HKT/SGT
ACDX全球首發Chia奇亞XCH槓桿交易
02:18 HKT/SGT
X World Games Secures $1.2 Million Funding led by Top Crypto Venture Funds
00:00 HKT/SGT
Friday, May 7, 2021
Blockchain and Liberty for All
20:16 HKT/SGT
Butterfly Protocol Announces New Program to Allow Full Blockchain Top-Level Domain Sponsorship and Control
19:28 HKT/SGT
Blockchain and Liberty for All
19:16 HKT/SGT
Butterfly Protocol Announces New Program to Allow Full Blockchain Top-Level Domain Sponsorship and Control
18:28 HKT/SGT
ACDX Offers World's First Leveraged Trading for Chia (XCH)
17:22 HKT/SGT
Global Internet of People Inc. Posts Robust 2020 Business Growth
16:00 HKT/SGT
与阿里升级战略合作 易居全资控股天猫好房
15:24 HKT/SGT
與阿里升級戰略合作 易居全資控股天貓好房
15:23 HKT/SGT
Global Internet of People Inc. Posts Robust 2020 Business Growth
15:00 HKT/SGT
Don Muang Tollway (SET:DMT) begins stock trading on SET
14:00 HKT/SGT
문스테이크, IOST 블록 체인과 파트너십 체결하며 IOST스테이킹 지원 예정 발표
12:00 HKT/SGT
MoonstakeとIOSTブロックチェーンが提携 IOSTのステーキング提供まもなく開始
12:00 HKT/SGT
Moonstake Partners with IOST Blockchain, Soon to Enable Support for IOST Staking
12:00 HKT/SGT
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications
10:08 HKT/SGT
エーザイ、「レンビマ」と「キイトルーダ」の併用療法について進行性腎細胞がんおよび進行性子宮内膜がんに係る申請が米国FDAより優先審査に指定
10:00 HKT/SGT
NECスペーステクノロジー、令和3年春の「黄綬褒章」を受章
10:00 HKT/SGT
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대
08:00 HKT/SGT
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
01:00 HKT/SGT
China Marks an Important Year of Promoting Carbon Neutrality
00:00 HKT/SGT
中國是促進碳中和的重要一年
00:00 HKT/SGT
中国是促进碳中和的重要一年
00:00 HKT/SGT
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
00:00 HKT/SGT
Thursday, May 6, 2021
全球公司董事会回应危机对管治的挑战 香港董事学会分享全球董事调查2020-2021结果
17:40 HKT/SGT
全球公司董事會回應危機對管治的挑戰 香港董事學會分享全球董事調查2020-2021結果
17:39 HKT/SGT
Corporate Boards Worldwide Navigating Governance Challenges, HKIoD Shares Findings of Global Director Survey 2020-2021
17:38 HKT/SGT
复盤美股SaaS軌跡尋找十倍賽道,CRM細分龍頭訊鳥軟件(IFBD.O)成長可期
17:03 HKT/SGT
复盘美股SaaS轨迹寻找十倍赛道,CRM细分龙头讯鸟软件(IFBD.O)成长可期
17:02 HKT/SGT
昭和電工、Infineon Technologiesとパワー半導体向けSiCエピタキシャルウェハーについて販売および共同開発契約を締結
16:30 HKT/SGT
Showa Denko and Infineon Technologies Conclude Supply Contract and Development Agreement
16:30 HKT/SGT
Filmmakers and National TV Stations May Submit Audio-Visual Productions with Original Music, Composers, Sound Designers May Compose for Films in FMC 2021
16:00 HKT/SGT
三菱重工と日本IBM、CO2流通を可視化するデジタルプラットフォーム「CO2NNEX」構築へ
15:50 HKT/SGT
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
13:13 HKT/SGT
NEC、複雑な意思決定を行う際の脳活動の知見を応用したAI技術を開発
13:10 HKT/SGT
Avance Clinical社、遺伝子技術を用いた臨床試験サービスを拡大 174億ドルの市場需要に対応
13:00 HKT/SGT
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
10:27 HKT/SGT
Fajarbaru upbeat on property segment's outlook in Malaysia and Australia
10:00 HKT/SGT
NEC、新型コロナウイルス(SARS-CoV-2)と結合する人工DNAアプタマーの開発に成功
10:00 HKT/SGT
Fajarbaru upbeat on property segment's outlook in Malaysia and Australia
09:00 HKT/SGT
The Place Holdings' Land Site at Mount Yuntai Tourism Township Revalued at RMB 481 Million, a Substantial Increment in Value of 329%
07:58 HKT/SGT
Wednesday, May 5, 2021
HKTDC's Start-up Fiesta kick-starts today
20:00 HKT/SGT
HKTDC's Start-up Fiesta kick-starts today
19:00 HKT/SGT
 ACN Search:
 
PERTAMINA PRIDE VLCC model replica for SOE Minister Erick Thohir and Pertamina President Director Nicke Widyawati with Directors of Pertamina and Pertamina International Shipping (PIS), symbolizing the inauguration at Semangka Bay, Lampung (4/15).
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575